OP0219 TLR2 differentially mediates A-SAA induced pro-inflammatory pathways in rheumatoid arthritis. (23rd January 2014)
- Record Type:
- Journal Article
- Title:
- OP0219 TLR2 differentially mediates A-SAA induced pro-inflammatory pathways in rheumatoid arthritis. (23rd January 2014)
- Main Title:
- OP0219 TLR2 differentially mediates A-SAA induced pro-inflammatory pathways in rheumatoid arthritis
- Authors:
- Rooney, P.
Gao, W.
McCormick, J.
Harty, L.
Veale, D.J.
Fearon, U.
Connolly, M. - Abstract:
- Abstract : Background: Acute Serum Amyloid A (A-SAA) is strongly expressed in rheumatoid arthritis (RA) synovial tissue (ST) and is critically involved in regulating cell migration and invasion. In this study we examine the effect of A-SAA on Notch and chemokine signalling pathways and examine if these effects are mediated through TLR2 activation. Methods: Expression of Notch 1 IC, downstream target genes HRT1, HRT2 and ligands JAGGED 1 and DLL-4 were assessed in synovial tissue and cells by Real-Time PCR and Western blot. Human microvascular endothelial cells (HMVEC) and primary Rheumatoid Arthritis Synovial Fibroblasts (RASFC) were cultured in the presence of anti-TLR2 or IgG control antibody. IL-6, IL-8, GROα and MCP-1 were assessed by ELISA, EC activation was assessed by matrigel tube formation and invasion assays. MMP expression in HMVEC and RASFC was assessed by real-time PCR, ELISA and gelatin zymography. Results: NOTCH-1, target genes HRT 1, HRT 2 and ligands JAGGED 1 and DLL-4 mRNA was demonstrated in RA and PsA synovial biopsies. A-SAA significantly induced Notch-1 IC protein expression (p<0.05), and HRT 1 and JAGGED 1 mRNA expression (p<0.05). In contrast DLL-4 mRNA was significantly inhibited in response to A-SAA (p<0.05). A-SAA significantly induced IL-6, IL-8, GROa and MCP-1 in HMVEC and RASFC, effects which were significantly inhibited by the presence of anti-TLR2 (all p<0.05). Furthermore, A-SAA induced EC activation and invasion were inhibited by anti-TLR2Abstract : Background: Acute Serum Amyloid A (A-SAA) is strongly expressed in rheumatoid arthritis (RA) synovial tissue (ST) and is critically involved in regulating cell migration and invasion. In this study we examine the effect of A-SAA on Notch and chemokine signalling pathways and examine if these effects are mediated through TLR2 activation. Methods: Expression of Notch 1 IC, downstream target genes HRT1, HRT2 and ligands JAGGED 1 and DLL-4 were assessed in synovial tissue and cells by Real-Time PCR and Western blot. Human microvascular endothelial cells (HMVEC) and primary Rheumatoid Arthritis Synovial Fibroblasts (RASFC) were cultured in the presence of anti-TLR2 or IgG control antibody. IL-6, IL-8, GROα and MCP-1 were assessed by ELISA, EC activation was assessed by matrigel tube formation and invasion assays. MMP expression in HMVEC and RASFC was assessed by real-time PCR, ELISA and gelatin zymography. Results: NOTCH-1, target genes HRT 1, HRT 2 and ligands JAGGED 1 and DLL-4 mRNA was demonstrated in RA and PsA synovial biopsies. A-SAA significantly induced Notch-1 IC protein expression (p<0.05), and HRT 1 and JAGGED 1 mRNA expression (p<0.05). In contrast DLL-4 mRNA was significantly inhibited in response to A-SAA (p<0.05). A-SAA significantly induced IL-6, IL-8, GROa and MCP-1 in HMVEC and RASFC, effects which were significantly inhibited by the presence of anti-TLR2 (all p<0.05). Furthermore, A-SAA induced EC activation and invasion were inhibited by anti-TLR2 (p<0.05). Conversly the presence of TLR2 had a nominal effect on MMP mRNA and protein expression. However we observed differential effects on Notch pathway signalling components. Conclusions: TLR2 differentially mediates A-SAA induced pro-inflammatory mechanisms involved in the pathogenesis of Rheumatoid Arthritis. Disclosure of Interest: P. Rooney: None Declared, W. Gao: None Declared, J. McCormick: None Declared, L. Harty: None Declared, D. Veale Grant/Research support from: Wyeth, GSK, Abbott, Opsona, Consultant for: Wyeth, GSK, Abbott, Pfizer, Schering Plough, Centocor, Speakers Bureau: Wyeth, GSK, Abbott, Pfizer, Schering Plough, Centocor, Mundipharma, U. Fearon: None Declared, M. Connolly: None Declared … (more)
- Is Part Of:
- Annals of the rheumatic diseases. Volume 71(2012)Supplement 3
- Journal:
- Annals of the rheumatic diseases
- Issue:
- Volume 71(2012)Supplement 3
- Issue Display:
- Volume 71, Issue 3 (2012)
- Year:
- 2012
- Volume:
- 71
- Issue:
- 3
- Issue Sort Value:
- 2012-0071-0003-0000
- Page Start:
- 130
- Page End:
- 130
- Publication Date:
- 2014-01-23
- Subjects:
- Rheumatism -- Periodicals
616.723005 - Journal URLs:
- http://ard.bmjjournals.com/ ↗
http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=149&action=archive ↗
http://www.bmj.com/archive ↗
http://gateway.ovid.com/server3/ovidweb.cgi?T=JS&MODE=ovid&D=ovft&PAGE=titles&SEARCH=annals+of+the+rheumatic+diseases.tj&NEWS=N ↗ - DOI:
- 10.1136/annrheumdis-2012-eular.1902 ↗
- Languages:
- English
- ISSNs:
- 0003-4967
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 17886.xml